Cargando…
Profitability and Market Value of Orphan Drug Companies: A Retrospective, Propensity-Matched Case-Control Study
BACKGROUND: Concerns about the high cost of orphan drugs has led to questions being asked about the generosity of the incentives for development, and associated company profits. METHODS: We conducted a retrospective, propensity score matched study of publicly-listed orphan companies. Cases were defi...
Autores principales: | Hughes, Dyfrig A., Poletti-Hughes, Jannine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074462/ https://www.ncbi.nlm.nih.gov/pubmed/27768685 http://dx.doi.org/10.1371/journal.pone.0164681 |
Ejemplares similares
-
Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019) -
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
por: Pijeira Perez, Yankier, et al.
Publicado: (2023) -
How to produce ‘marketable and profitable results for the company’: from viral interference to Roferon A
por: Timmermann, Carsten
Publicado: (2019) -
Strategic Database Marketing 4e: The Masterplan for Starting and Managing a Profitable, Customer-Based Marketing Program
por: Hughes, Arthur
Publicado: (2011) -
Orphan drugs: Unmet societal need for non-profitable privately supplied new products
por: Moors, Ellen H.M., et al.
Publicado: (2007)